product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
Human Osteoprotegerin/TNFRSF11B Antibody
catalog :
MAB805-100
quantity :
100 ug (also 25 ug, 500 ug)
price :
439 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
69146
reactivity :
human
application :
western blot, immunohistochemistry, neutralization
more info or order :
citations: 10
Reference
Chatzidionysiou K, Circiumaru A, Rethi B, Joshua V, Engstrom M, Hensvold A, et al. Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKL. RMD Open. 2021;7: pubmed publisher
McLane J, Ligon L. Stiffened Extracellular Matrix and Signaling from Stromal Fibroblasts via Osteoprotegerin Regulate Tumor Cell Invasion in a 3-D Tumor in Situ Model. Cancer Microenviron. 2016;9:127-139 pubmed publisher
Jiao K, Niu L, Li Q, Chen F, Zhao W, Li J, et al. Biphasic silica/apatite co-mineralized collagen scaffolds stimulate osteogenesis and inhibit RANKL-mediated osteoclastogenesis. Acta Biomater. 2015;19:23-32 pubmed publisher
Revu S, Neregård P, af Klint E, Korotkova M, Catrina A. Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate. Arthritis Res Ther. 2013;15:R205 pubmed
Funck Brentano T, Lin H, Hay E, Ah Kioon M, Schiltz C, Hannouche D, et al. Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism. PLoS ONE. 2012;7:e33543 pubmed publisher
Zinonos I, Labrinidis A, Lee M, Liapis V, Hay S, Ponomarev V, et al. Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo. J Bone Miner Res. 2011;26:630-43 pubmed publisher
Locklin R, Federici E, Espina B, Hulley P, Russell R, Edwards C. Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis. Mol Cancer Ther. 2007;6:3219-28 pubmed
Makrygiannakis D, af Klint E, Catrina S, Botusan I, Klareskog E, Klareskog L, et al. Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis. Arthritis Rheum. 2006;54:1463-72 pubmed
Fonseca J, Cortez Dias N, Francisco A, Sobral M, Canhao H, Resende C, et al. Inflammatory cell infiltrate and RANKL/OPG expression in rheumatoid synovium: comparison with other inflammatory arthropathies and correlation with outcome. Clin Exp Rheumatol. 2005;23:185-92 pubmed
Mandelin J, Li T, Hukkanen M, Liljeström M, Salo J, Santavirta S, et al. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K. J Rheumatol. 2005;32:713-20 pubmed
product information
master code :
MAB805
SKU :
MAB805-100
product name :
Human Osteoprotegerin/TNFRSF11B Antibody
unit size :
100 ug (also 25 ug, 500 ug)
description :
The Human Osteoprotegerin/TNFRSF11B Antibody from R&D Systems is a mouse monoclonal antibody to Osteoprotegerin/TNFRSF11B. This antibody reacts with human. The Human Osteoprotegerin/TNFRSF11B Antibody has been validated for the following applications: Immunoprecipitation,Western Blot,Neutralization,Immunohistochemistry.
target :
Osteoprotegerin/TNFRSF11B
category :
Primary Antibodies
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 ╡m filtered solution in PBS.
clonality :
Monoclonal
clone :
69146
conjugate :
Unconjugated
host :
Mouse
immunogen :
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human Osteoprotegerin/TNFRSF11B, Glu22-Leu401, Accession # AAB53709
isotype :
IgG1
purity :
Protein A or G purified from ascites
species :
Human
specificity :
Detects human Osteoprotegerin/TNFRSF11B in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant mouse Osteoprotegerin is observed.
gene symbol :
TNFRSF11B
endotoxin note :
<0.10 EU per 1 ╡g of the antibody by the LAL method.
top caption :
Osteoprotegerin/TNFRSF11B Inhibition of TRAIL/ TNFSF10-induced Cyto-toxicity and Neutral-ization by Human Osteoprotegerin/ TNFRSF11B Antibody.
accessionNumbers :
AAB53709
applications :
Western Blot,Neutralization,Immunohistochemistry
USD :
439 USD
alt names :
OCIF, OCIFMGC29565, OPG, OPGtumor necrosis factor receptor superfamily member 11B, Osteoclastogenesis inhibitory factor, Osteoprotegerin, TNFRSF11B, TR1, tumor necrosis factor receptor superfamily, member 11b
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 6 months, -20 to -70 ░C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.